UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048469
Receipt number R000055239
Scientific Title Diabetic Registry in Chikugo District
Date of disclosure of the study information 2022/07/26
Last modified on 2022/07/26 17:34:48

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Diabetic Registry in Chikugo District

Acronym

Diabetic Registry in Chikugo District

Scientific Title

Diabetic Registry in Chikugo District

Scientific Title:Acronym

Diabetic Registry in Chikugo District

Region

Japan


Condition

Condition

Diabetes mellitus

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to establish a database for improving the treatment of diabetes.

Basic objectives2

Others

Basic objectives -Others

Others

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Distribution of various parameters related to glucose metabolism

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

All patients, except those who did not wish to be enrolled in the study, were informed of the study by posting the details of the study on the website.

Key exclusion criteria

Patients who did not wish to be enrolled in this study

Target sample size

5000


Research contact person

Name of lead principal investigator

1st name Nobuhiko
Middle name
Last name Wada

Organization

Department of Internal Medicine, Kurume University School of Medicine

Division name

Division of Endocrinology and Metabolism

Zip code

830-0011

Address

67 Asahi-machi, Kurume-shi, Fukuoka, Japan

TEL

0942-31-7563

Email

wada_nobuhiko@kurume-u.ac.jp


Public contact

Name of contact person

1st name Nobuhiko
Middle name
Last name Wada

Organization

Department of Internal Medicine, Kurume University School of Medicine

Division name

Division of Endocrinology and Metabolism

Zip code

830-0011

Address

67 Asahi-machi, Kurume-shi, Fukuoka, Japan

TEL

0942-31-7563

Homepage URL


Email

wada_nobuhiko@kurume-u.ac.jp


Sponsor or person

Institute

Kurume University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of Kurume University School of Medicine

Address

67 Asahi-machi, Kurume-shi, Fukuoka, Japan

Tel

0942-31-7563

Email

i_rinri@kurume-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 07 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

783

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 05 Month 21 Day

Date of IRB

2018 Year 06 Month 29 Day

Anticipated trial start date

2018 Year 06 Month 29 Day

Last follow-up date

2023 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Items of medical information to be registered
Medical history, diagnosis, age, age at diagnosis, sex, height, weight, abdominal circumference, grip strength, body composition, family history, medical history, lifestyle history (alcohol, tobacco, etc.), treatment details, blood tests (HbA1c, blood sugar including sugar metabolism related, liver function, kidney function, lipids, thyroid function, blood count, CRP, bone metabolism markers, etc.), urine test (occult blood, protein, albumin), fecal examination (occult blood, fat), bone mineral density, tendon reflexes, vibratory perception, gait speed, neck examination, etc. protein, albumin), fecal examination (occult blood, fat), bone mineral density, cognitive function evaluation, sleep evaluation, fundus examination, tendon reflexes, vibration perception, gait speed, carotid artery echo


Management information

Registered date

2022 Year 07 Month 26 Day

Last modified on

2022 Year 07 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055239


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name